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WHAT THIS PAPER ADDS
 Varicose veins affect one-third of adults in western population. Complications of the disease such as leg oedema and ulceration
affect the patients’ health and lifestyle. Pathogenesis of primary varicose veins is unclear. This novel study has elucidated the
metabolic proﬁle of intact varicose vein as compared to non-varicose vein. Understanding the signiﬁcance of differential metabolic
proﬁle in future may untangle the biological mechanism of disease initiation and progression.a r t i c l e i n f o
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Objectives: Nuclear magnetic resonance (NMR) spectroscopy is an established tool for metabolic proﬁling
of tissues or bioﬂuids with utility in identifying disease biomarkers and changes in enzymatic or gene
expression. This pilot study aims to compare the metabolic proﬁles of intact varicose and non-varicose
vein tissue via magic angle spinning (MAS) NMR spectroscopy with a view to promoting the under-
standing of the pathogenesis of varicose vein formation.
Methods: Varicose vein tissue (n ¼ 8) was collected from patients undergoing varicose veins surgery.
Control non-varicose great saphenous vein samples were collected from patients undergoing lower limb
amputation (n ¼ 3) and peripheral arterial bypass surgery (n ¼ 5). Intact tissue samples (average weight
10.33  0.8 mg) from each vein segment were analysed using 1D MAS 1H NMR (600 MHz) spectroscopy.
For selected vein samples, two-dimensional (2D) NMR experiments were performed. Differences
between spectra from varicose and non-varicose tissues were elucidated using a variety of multivariate
statistical analyses.
Results: The metabolic proﬁles of varicose veins samples were clearly differentiated from non-varicose
veins samples. Lipid metabolites were present at a higher concentration in the non-varicose veins
group whilst creatine, lactate andmyo-inositol metabolites were more characteristic of the varicose veins
group.
Conclusion: We demonstrate differential metabolic proﬁles between varicose veins and non-varicose
veins. Elucidating the metabolic signature underlying varicose veins can further improve our under-
standing of the biological mechanisms of disease initiation, progression, and aid in identifying putative
therapeutic targets.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.ection of Vascular Surgery,
Road, London W6 8RF, UK.
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Varicose veins affect one-third of adults in the Western world.1
Marked morphological differences clearly distinguish varicose
veins from non-varicose veins. Varicose veins also exhibit expres-
sion of various transcripts and proteins linked to speciﬁc genes
regulating cell growth and apoptosis, extracellular matrix metab-
olism and inﬂammatory processes.2e4 Studies have also looked ated by Elsevier Ltd. All rights reserved.
Table 1
Patient demographic and clinical features of varicose veins and non-varicose veins
groups.
Varicose veins
(n ¼ 8)
Non-varicose veins
(n ¼ 8)
Age, mean (range) years 42 (31e62) 69 (32e94)
Gender 6 Male/2 female 7 Male/1 female
Smoker 4 2
Ischaemic heart disease 0 2
Hypertension 1 7
Malignancy 0 0
Peripheral arterial disease 0 7
Deep venous thrombosis 0 0
Diabetes 0 3
Connective tissue disease 0 0
Steroid use 0 0
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hybridisation techniques.5,6 Evidence has strongly suggested that
primary vein wall pathology is a major contributor in the devel-
opment of varicose veins.7,8 However, transcriptomic (study of
individuals’ gene expression as RNA) and proteomic (study of
translation of RNA into proteins) analyses have not yet allowed
elucidation of the cellular and molecular changes described in the
wall of varicose veins, or the mechanisms responsible for disease
progression.
Metabonomics is deﬁned as “the quantitative measurement of
the dynamicmulti-parametric metabolic response of living systems
to pathophysiological stimuli or genetic modiﬁcation.”9 Metabo-
lites are intermediate or end-products of cellular metabolism and
hold key information regarding ongoing biological processes.
When exposed to radiofrequency pulses in an external magnetic
ﬁeld, magnetically active atomic nuclei such as protons in a bio-
logical sample show slight differences in their transition frequency
depending upon their immediate electronic and chemical envi-
ronment. These differences are the basis of the spectral ﬁngerprint
containing discrete signals reﬂecting multiple metabolites and
their concentrations.10
Various stimuli including disease, diet and drugs affect cellular
metabolism and hence the metabolite pools in the extracellular
tissues and ﬂuids are affected as a result of this altered metabo-
lism.11 High-resolution magic angle spinning (MAS)-nuclear
magnetic resonance (NMR) spectroscopy is a non-destructive
approach to analyse intact tissue and is found to be valuable in
providing information regarding the metabolites’ concentration
and compartmentalisation within the tissues.12,13 Several studies
have demonstrated toxicological and diagnostic applications of
high-resolution MAS-NMR spectroscopy of intact tissues including
colonic, renal and hepatic tissues.12,14,15 The biochemical compo-
sition of tissue spectra collected by MAS-NMR is then analysed via
mathematical modelling using chemometric software to extract
and identify robust information on cellular biological events. This
can lead to the elucidation of cellular pathways, provide informa-
tion on gene or enzyme functions and can aid in the determination
of the inﬂuence, efﬁcacy and toxicity of targeting therapeutics.9,13,16
Identifying new cellular pathways using metabonomic
approaches may address the undisclosed biological events, which
have not been picked up by other systems biology approaches,
including transcriptomics and proteomics. This preliminary study
aims to assess the viability of using a metabonomic approach to
investigate the biochemical composition of vein wall tissue and to
explore the pathogenesis of varicose veins disease, which may help
to improve our understanding of its aetiology and its management.
Methods
Research ethics committee approval was obtained from the
Riverside Research Ethics Committee, London, UK. Varicose veins
were collected from patients undergoing surgery for lower
extremity varicose veins (n ¼ 8). The presence of truncal reﬂux in
the great saphenous vein (GSV) was conﬁrmed and vein marking
was undertaken, both using duplex ultrasound prior to surgery.
Retrieved GSV varicose samples were also inspected carefully to
select for analysis only dilated and tortuous vein segments. Three
control non-varicose GSV samples were collected from patients
undergoing lower limb amputation and ﬁve non-varicose GSV
samples from individuals having peripheral arterial bypass surgery.
Each vein sample was collected fresh at the time of surgery, snap
frozen in liquid nitrogen and stored at 80 C. The entire circum-
ference of vein tissuewas cut using a sterile scalpel and forceps; any
peri-vascular fat was gently removed. To assess tissue homogeneity
within an individual sample and to establishwhether themetabolicproﬁle is relatively uniform across a length of vein tissue, one vein
segment from each group (varicose and non-varicose veins control)
was divided into three adjacent parts and analysed independently.
In total, 10 samples from eight varicose veins patients and 10
samples from eight non-varicose veins control patients were ana-
lysed. Due to ethical limitations upon the study design, patients
from whom varicose veins tissue samples were obtained were
younger and had fewer co-morbidities as compared with those
from whom non-varicose veins were collected (Table 1).
Each sample was weighed (average weight 10.33  0.8 mg).
Intact tissue samples were prepared as previously described13,14
and spun at 5 kHz in high-resolution MAS 600 MHz 1H-NMR
spectroscope (Bruker BioSpin, Rheinstetten, Germany).
NMR spectroscopy of vein tissue
Standard one-dimensional spectra were used with suppression
of the water signal to adjust the dynamic range to the metabolites
of interest. The CarrePurcelleMeiboomeGill (CPMG) spin-echo
pulse sequence was also applied in a second measurement to
reduce effects of broader resonances from high-molecular-weight
compounds, therefore enabling sharp resonances from low-
molecular-weight compounds to be easily identiﬁed. A total
spinespin relaxation time of 120 ms was chosen (n ¼ 300,
s ¼ 200 ms). For each sample, 256 scans were acquired into 64 K
data points. Spectral width of d 20 ppm was used with relaxation
delay of 2 s and acquisition time of 2.72 s. Each spectrum was
phased, calibrated using the chemical shift of the alanine methyl
group at d1.48 or the b-glucose (1H) doublet at d 4.644, and baseline
was corrected using TOPSPIN 2.0a software (Bruker BioSpin,
Rheinstetten, Germany).
Chemometric analysis of NMR spectra
Spectra were imported into MATLAB R2009b (Mathworks,
2009) using in-house software. The region containing the water
resonances (from d4.68 to d5.24) was removed from each spec-
trum and all spectra were subsequently aligned and normalised
using probabilistic quotient normalisation.17 Data were transferred
to SIMCA-Pþ 11.5 statistical software (UMETRICS, Sweden).
Principal components analysis (PCA) and orthogonal partial least
square regression (OPLS) analysis were employed using unit
variance (UV) scaled data to identify the presence of inherent
similarities in the data and investigate whether the varicose veins
group systematically differed in biochemical composition from the
control group. OPLS is a supervised linear regression approach
which can model separately the co-varying variation from
structured noise (orthogonal variation), while simultaneously
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between two groups.18 An in-house mathematical modelling
algorithm in MATLAB (Mathworks, 2009) was employed to iden-
tify the strength of correlation of the inﬂuential metabolite peaks
with a particular class. The colour-coded orthogonal 2 partial least
square (O2PLS) regression coefﬁcient plot identiﬁes the strength of
correlation of a metabolite to a particular tissue type, therefore
highlighting signiﬁcant differences between varicose and non-
varicose veins. We performed receiver operating characteristic
(ROC) curve analysis to examine the diagnostic accuracy of partial
least-squares driven class discrimination. An area between 0.9 and
1 under the ROC curve represents a strong diagnostic accuracy of
the model.19
Individual metabolite identities were assigned by using data
from other studies examining human tissue metabolic proﬁles via
MAS NMR and using the human metabolome database.12,14,20e22
The assignments were conﬁrmed by two-dimensional (2D) NMR
experiments on selected varicose veins and non-varicose veins
samples, and through the use of the Bruker Amix/SBase database.
2D NMR disperses the data into two spectra showing mainly
correlation between adjacent protons (1He1H Correlation
Spectroscopy or COSY) or proton and carbon atoms 1He13C
heteronuclear single quantum coherence (HSQC) spectroscopy,
facilitating elucidation of the structure of each metabolite.13,21
J-resolved spectra which display the coupling patterns and
J-coupling values in a second orthogonal dimension were also
used to identify metabolites and interpret overlapping signal
patterns.23
Results
1H NMR spectra from all samples with relevant varicose (n¼ 10)
and non-varicose veins (n ¼ 10) spectra are shown in Fig. 1.
Assigned spectra from each group are shown in Figs. 2 and 3.
Spectral similarities within each group and differences between the
two groups of veins were evident. The large peaks of triglycerides
(unsaturated and saturated) were found in abundance in theFigure 1. Spectra from 10 non-varicose vein samples and 10 varicose vein samples. Similarit
the group. In comparison, 10 spectra from non-varicose vein samples are different to the var
from the single vein segment of a patient of that group. There is clearly more intra-segmenon-varicose veins group (Fig. 2). Creatine, myo-inositol, lactate
and glutamate were found in relatively higher levels in varicose
veins tissues (Fig. 3). These ﬁndings were supported by the results
of 2D NMR on selected vein tissue.
Analysis of the PCA scores plot of CPMG spectra of varicose and
non-varicose veins (Fig. 4a) showed that the variance in the ﬁrst
two components was skewed by two outliers. These outliers were
two samples out of a series of three biological replicates from the
same vein. Outlier samples contained substantially higher
concentrations of triglycerides compared to other samples.
However, after exclusion of these two outlying samples, variation
was still relatively higher in the non-varicose veins group
compared to varicose veins samples (Fig. 4b).
There was evidence for clustering of a subset of the samples
from the varicose veins group and so OPLS analysis was used to
identify systematic variation relating to disease class. To avoid
potential bias in OPLS discriminatory analyses, only one out of three
replicates from the same vein segment in each group was included
for the OPLS discriminatory analysis. Although the number of
samples in this pilot study was small, the OPLS scores plot (Fig. 5)
clearly highlights the separation of the two groups, with tighter
clustering of the varicose veins samples compared to non-varicose
veins samples.
Examination of the O2PLS coefﬁcients plot showed that crea-
tine, myo-inositol and lactate were highly correlated with the
varicose veins group (Fig. 6). The ROC curve analysis conﬁrmed that
the diagnostic accuracy of our model was excellent with an area
under the curve score of 0.92 (Fig. 7).
Discussion
We observed that the metabolic proﬁles of varicose veins vary
signiﬁcantly from non-varicose veins. The main differentiating
biomarkers are creatine, myo-inositol and lactate, which were
higher in varicose veins tissue than non-varicose veins tissue. On
the other hand, triglycerides were found in abundance in non-
varicose veins.ies of spectral peaks within the varicose veins group representing homogeneity within
icose veins spectra. Spectra coloured in blue in each group represent the samples taken
ntal versus inter-sample homogeneity.
Figure 2. Magic Angle Spinning-1H NMR (600 MHz) CarrePurcelleMeiboomeGill (CPMG) spectrum detailing the metabolic proﬁles of a non-varicose vein tissue.
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and also synthesised in the liver. It is stored in skeletal muscle
where it acts as a cellular energy source.24 Intracellular adenosine
triphosphate (ATP) transfers its phosphate group to creatine toform phosphocreatine.25 Phosphocreatine is found in a concen-
tration ranging between 20 and 35 mM in skeletal muscle cells
and 5e10 mM in other excitable tissue including brain and smooth
muscle.25 In our study, varicose veins samples were observed to be
Figure 3. Magic Angle Spinning-1H NMR (600 MHz) CarrePurcelleMeiboomeGill (CPMG) spectrum listing the metabolic proﬁles of a varicose vein tissue.
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smooth muscle mass in the varicose veins wall is therefore
responsible for the creatine abundance observed in this group.
However, varicose veins can also have smooth muscle atrophy and
be thin walled; therefore, inclusion of a large sample including
both thin and thick-walled varicose veins, with metabolite
extraction for NMR and mass spectrometry analysis, is recom-
mended for future studies.
Myo-inositol, in addition to regulating intracellular osmolality in
the brain,26 forms a structural component of the phosphatidyli-
nositol and phosphatidylinositides, which function as second
messengers. Phosphatidylinositides are involved in lipid signalling
and cell signalling via intracellular pathways containing phospha-
tidylinositol kinases,27,28 protein kinase C and nuclear factor kappa
B (NFkB).29,30 NFkB signalling plays a role in the regulation of
adhesion molecules, cytokines, chemokines, growth factors and
matrix metalloproteinases (MMPs) in vascular cells.31,32 Varicose
veins have been found to be associatedwith upregulation of growth
factors, including vascular endothelial growth factor, transforminggrowth factor-b1 and acidic ﬁbroblast growth factors.4,33,34 Simi-
larly, inﬂammatory cytokines and adhesions molecules have been
considered to be involved in vein valve insufﬁciency.35 Alteration in
levels and activity of MMPs and their inhibitors have been impli-
cated in the pathogenesis of varicose veins.36
Excess lactate represents increased anaerobic metabolism of
pyruvate by the lactate dehydrogenase (LDH) enzyme,37 which
occurs in a number of states including hypoxia. Importantly,
hypoxia and increased activation of hypoxia-inducible pathway
have been recently implicated in the pathogenesis of varicose
veins.38,39 Increased activity of the anaerobic fraction of LDH has
also been reported in varicose veins suggesting increased anaerobic
glycolysis in this context.40 Association of the metabolites lactate
andmyo-inositol with such key signalling pathways proposes these
pathways for future research.
To our knowledge, this is the ﬁrst study to characterise the
metabolic proﬁle of varicose veins by NMR spectroscopy. From this
study, it is apparent that metabonomic techniques are suitable for
characterising vein pathology. A limitation of our study is that the
ab
Figure 4. Principal components analysis (PCA) scores plot of varicose vein and non-varicose vein CPMG spectra, showing variance between samples and the direction of the largest
variance in the data. Each - or represents a vein sample. Percentage of variation in the NMR data explained by ﬁrst and second principal components were 79% and 8%,
respectively, in the presence of all replicates (a), and 53% and 19%, respectively, when two out of three replicates were removed from each group (b). Varicose vein samples are
grouped together in the unsupervised PCA analysis. Intra-segmental versus inter-sample homogeneity is also noticeable in the non-varicose veins group.
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group in terms of demographic features, past medical history and
medications. Factors such as age, medications and past medical
history may inﬂuence the metabolic proﬁle of vein tissue. However,
to our knowledge, there has been no demonstration of the effect of
age onmetabolic proﬁle of vein tissue so far. Statins andmost of the
other cardiovascular medications have a short half-life (less than
24 h)41 and neither parent statins nor their metabolites wereFigure 5. Orthogonal partial least square (OPLS) analysis separating the two classes
(varicose and non-varicose veins) based on their metabolic proﬁles detected using
MAS-1H NMR. Probabilistic quotient normalisation and unit variance settings were
applied for data analysis. R2Ycum was 0.788 and Q2cum was 0.406 for orthogonal
component. Q2 indicates the fraction of variation predicted by the model for cross
validation. One non-varicose vein sample is closer to the varicose veins group (spec-
trum 5 in Fig. 1).detected in the NMR proﬁles. Although this does not evade the
possibility that an endogenousmetabolic response to chronic use of
statins might be detected, in light of the nature of the metabolic
changes it seems unlikely that statins would be responsible for any
of the observed differences in metabolic proﬁle between the vari-
cose vein and control groups. Each vein segment was washed with
deuterium oxide before the experiment. It is challenging to obtain
non-varicose vein control tissue from age-matched (often young
and otherwise healthy) individuals. Use of inferior epigastric vein
retrieved at inguinal hernia surgery may facilitate patient match-
ing. However, this will not reﬂect the relevant haemodynamic
stresses to which a GSV is exposed. We further plan to examine
control vein tissue fromvarious anatomical regions, including facial
vein at the time of carotid endarterectomy, arm vein during hae-
modialysis ﬁstula formation, inferior epigastric veins from inguinal
hernia repairs and inferior mesenteric vein from bowel resections,
to document any metabolic differences between the veins from
different anatomical regions and to assign a metabolic proﬁle of
non-varicose vein.
This study uses 1H MAS NMR spectroscopy to rapidly obtain
a picture of the metabolic proﬁle of vein tissue. Furthermore,
metabolites can also be extracted from tissue and analysed by NMR.
Correlation of metabolic proﬁles with histopathological analysis of
tissue samples may further advance our understanding of the
pathophysiology of varicose veins. These approaches will form part
of our ongoing investigative plan, to be applied in larger sample
sets, for establishing differential metabolic signature of varicose
veins as compared to non-varicose veins.
Figure 6. O2PLS co-efﬁcient plot showing 1H NMR CPMG spectral data of veins using MAS technology. Spectra have been processed using probabilistic quotient normalisation and
unit variance scaling. Red peaks represent highly correlated metabolites to the respective group and are responsible for the distinction between the two groups, yellow are less
variable metabolites, and blue the least correlated. Highly correlated metabolites to the varicose veins group are creatine, lactate and myo-inositol. Statistical total correlated
spectroscopy (STOCSY) of metabolic features at d3.26 conﬁrms the correlation of myo-inositol peaks.
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Figure 7. Receiver operating characteristic (ROC) curve diagnostic analysis for
predictive O2PLS model. Area under the curve score of 0.9218 shows excellent
predictive accuracy of our model.
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This preliminary study demonstrates differential metabolic
expression in varicose as compared with non-varicose veins.
Elucidating the metabolic signature underlying varicose vein
disease has the potential to further our understanding of biological
mechanisms of disease initiation and progression, identify putative
biomarkers and targets for prevention and treatment and merits
further explanation.
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